- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By 
Jeff Dale2023-08-29T18:41:00
A Florida-based provider of oxygen equipment for patients with respiratory ailments agreed to pay $29 million to resolve allegations it violated the False Claims Act by fraudulently overbilling Medicare.
Lincare Holdings, a subsidiary of German multinational chemical corporation Linde, admitted to improperly billing Medicare, Medicare Advantage plans, and beneficiaries for leased oxygen equipment the company had already been reimbursed for by the government, U.S. Attorney for the Eastern District of Washington Vanessa Waldref announced in a press release Monday.
The settlement resolves a lawsuit brought under the qui tam provisions of the False Claims Act by two former Lincare employees, Benjamin Montgomery and Brandon Haugen, who will receive more than $5.6 million.
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
Lincare, a supplier of durable medical equipment, agreed to pay $25.5 million to settle allegations it billed federal health programs for the rental of ventilator machines after patients no longer needed to use them.
Cardiac Imaging and its chief executive agreed to pay a total of more than $85 million to settle charges levied by the Department of Justice addressing alleged violations of the False Claims Act regarding unlawful kickbacks.
Multinational health insurance company Cigna agreed to pay more than $172 million as part of a settlement with the Department of Justice addressing allegations it submitted and failed to withdraw false claims to Medicare.
USAA Federal Savings Bank has been hit with its third cease and desist order from the Treasury Department’s Office of the Comptroller of the Currency in the past five years for failing to correct unsafe and unsound banking practices.
Becton Dickinson medical device company will pay $175 million for “repeatedly” misleading investors about its Alaris infusion pump, a product the company knew was flawed and was sold without the required patient-safety approvals, the Securities and Exchange Commission said.
The Securities and Exchange Commission charged bankrupt fashion retailer Express with failing to disclose nearly $1 million in perks to a former chief executive, but did not levy a financial penalty thanks to its cooperation, the SEC said.
